Lorcaserin for Weight Loss Management in Patients on Antipsychotics: A Pilot Study

NCT01962402 ↗

Phase 4 Unknown 15 enrolled Southern California Institute for Research and Education

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether lorcaserin is effective for weight reduction in patients with weight gain as a result of antipsychotic medications.

Timeline

Start: 2014-01
Primary completion: 2015-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lorcaserin	Small molecule	10 mg	Oral

Indications

No indication recorded.